1.Crump, JA, Luby, SP, Mintz, ED. The global burden of typhoid fever. Bulletin of the World Health Organization 2004; 82: 346–353.
2.Basnyat, B, et al. Enteric (typhoid) fever in travelers. Clinical Infectious Disease 2005; 41: 1467–1472.
3.Bhan, MK, Bahl, R, Bhatnagar, S. Typhoid and paratyphoid fever. Lancet 2005; 366: 749–762.
4.Connor, BA, Schwartz, E. Typhoid and paratyphoid fever in travellers. Lancet Infectious Diseases 2005; 5: 623–628.
5.Kubota, K, et al. Analysis of Salmonella enterica serotype Typhi pulsed-field gel electrophoresis patterns associated with international travel. Journal of Clinical Microbiology 2005; 43: 1205–1209.
6.Guzman, CA, et al. Vaccines against typhoid fever. Vaccine 2006; 24: 3804–3811.
7.Brachman, PS. Control of Communicable Diseases Manual, 17th edn. Washington, DC: American Public Health Association, 2000.
8.Pang, T, et al. Typhoid fever – important issues still remain. Trends in Microbiology 1998; 6: 131–133.
9.Rowe, B, Ward, LR, Threllfall, EJ. Multidrug-resistant Salmonella Typhi: a worldwide epidemic. Clinical Infectious Disease 1997; 24: S106–S109.
10.WHO. Background paper on vaccination against typhoid fever using new-generation vaccines. Proceedings of the SAGE Meeting (November 2007). World Health Organization, 2007.
11.Ackers, ML, et al. Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise. Journal of the American Medical Association 2000; 283: 2668–2673.
12.Hampton, MD, et al. Molecular fingerprinting of multi-drug resistant Salmonella enterica serotype Typhi. Emerging Infectious Disease 1998; 4: 317–320.
13.Kumar, S, Rizvi, M, Berry, N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. Journal of Medical Microbiology 2008; 57: 1247–1250.
14.Chau, TT, et al. Antimicrobial drug resistance in Salmonella enterica serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrobial Agents and Chemotherapy 2007; 51: 4315–4323.
15.Crump, JA, et al. Clinical response and outcome of infection with S. Typhi with decreased susceptibility to fluoroquinolones: a United States FoodNet multi-center retrospective cohort study. Antimicrobial Agents and Chemotherapy 2008; 52: 1278–1284.
16.Ben Saida, N, et al. Genotypic analysis of Salmonella enterica serovar Typhi collected during two successive autumnal typhoid outbreaks in southeast Tunisia. Pathological Biology 2007; 55: 336–339.
17.Kam, KM, et al. Molecular characterization of Salmonella enterica serotype Typhi isolates by pulsed-field gel electrophoresis in Hong Kong, 2000–2004. Foodborne Pathogens and Disease 2007; 4: 41–49.
18.Lewis, MD, et al. Typhoid fever: a massive, single-point source, multidrug-resistant outbreak in Nepal. Clinical Infectious Disease 2005; 40: 554–561.
19.Salve, A, et al. Molecular subtyping of Salmonella enterica serovar Typhi isolates from Colombia and Argentina. Foodborne Pathogens and Disease 2006; 3: 142–152.
20.Thong, KL, Bhutta, ZA, Pang, T. Multidrug-resistant strains of Salmonella enterica serotype Typhi are genetically homogeneous and coexist with antibiotic-sensitive strains as distinct, independent clones. International Journal of Infectious Disease 2000; 4: 194–197.
21.Anderson, ES, Williams, REO. Bacteriophage typing of enteric pathogens and Staphylococci and its use in epidemiology. Journal of Clinical Pathology 1956; 9: 94–127.
22.Arbeit, RD. Laboratory procedures for epidemiologic analysis of microorganisms. In: Yolken, RH, editor. Manual of Clinical Microbiology, 6th edn. Washington, DC: ASM Press, 1995, pp. 190–208.
23.Cooke, FJ, et al. Cases of typhoid fever imported into England, Scotland and Wales (2000–2003). Transactions of the Royal Society of Tropical Medicine and Hygiene 2007; 101: 398–404.
24.Nair, S, et al. Genome fingerprinting of Salmonella Typhi by pulsed-field gel electrophoresis for subtyping common phage types. Epidemiology and Infection 1994; 113: 391–402.
25.Navarro, F, et al. Molecular typing of Salmonella enterica serotype Typhi. Journal of Clinical Microbiology 1996; 34: 2831–2834.
27.Ewing, WH. Edwards and Ewing's Identification of Enterobacteriaceae, 4th edn. New York: Elsevier, 1986, pp. 181–245.
28.Popoff, MY. Antigenic Formulas of the Salmonella Serovars, 8th edn. Paris: WHO Collaborating Center for Reference and Research on Salmonella, 2001.
29.Adams, MH. Bacteriophages. New York: Interscience Publishers, 1959.
30.Farmer, JJ, Hickman, FW, Sikes, JV. Automation of Salmonella Typhi phage-typing. Lancet. 1975; ii: 787–790.
31.Barrett, TJ, et al. Laboratory investigation of a multi-state food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. Journal of Clinical Microbiology 1994; 32: 3013–3017.
32.Centers for Disease Control. Standardized molecular subtyping of foodborne bacterial pathogens by pulsed-field gel electrophoresis. The National molecular subtyping network for foodborne disease surveillance. Centers for Disease Control, Atlanta, Georgia, 1998.
33.Public Health Agency of Canada. General PFGE of Escherichia coli, Salmonella spp., Shigella spp. Standard operating procedure, PNC-PR-210. PulseNet Canada. 2008.
34.Public Health Agency of Canada. BioNumerics and PulseNet master scripts for PFGE pattern identification. Standard operating procedure, PNC-PR-300. PulseNet Canada. 2006.
35.Bauer, AW, et al. Antibiotic testing by standardized single disk method. American Journal of Clinical Pathology 1996; 45: 493–6.
36.National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test, 5th edn. Approved standard M2-A5. National Committee for Clinical Laboratory Standards, Wayne, PA, 1993.
37.National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Document M100-S12. National Committee for Clinical Laboratory Standards, Wayne, PA, 2000.
38.National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, PA, 2000.
41.Centers for Disease Control.National antimicrobial resistance monitoring system for enteric bacteria (NARMS): human isolates final report, 2004. Centers for Disease Control, Atlanta, Georgia, 2007.
42.Swaminathan, B, et al. Building PulseNet International: an interconnected system of laboratory networks to facilitate timely public health recognition and response to foodborne disease outbreaks and emerging foodborne diseases. Foodborne Pathogens and Disease 2006; 3: 36–50.
43.Fica, A, et al. Epidemic typhoid in Chile: analysis by molecular and conventional methods of Salmonella Typhi strain diversity in epidemic (1997 and 1981) and nonepidemic (1990) years. Journal of Clinical Microbiology 1996; 34: 1701–1707.
44.Mirza, S, et al. Analysis of plasmid and chromosomal DNA of multidrug-resistant Salmonella enterica Serovar Typhi from Asia. Journal of Clinical Microbiology 2000; 38: 1449–1452.
45.Mermin, JH, et al. Typhoid fever in the United States, 1985–1994: changing risks of international travel and increasing antimicrobial resistance. Archives of Internal Medicine 1998; 158: 633–638.
46.Thong, KL, et al. Analysis of Salmonella Typhi isolates from Southeast Asia by pulsed-field gel electrophoresis. Journal of Clinical Microbiology 1995: 33; 1938–1941.
47.Rice, PA, Baine, WB, Gangarosa, J. Salmonella Typhi infection in the United States, 1967–1972: increasing importance of international travelers. American Journal of Epidemiology 1977; 106: 160–166.
48.Ryan, CA, Hargrett-Bean, NT, Blake, PA. Salmonella Typhi infections in the United States, 1975–1984: increasing role of foreign travel. Reviews of Infectious Diseases 1989; 11: 1–8.
50.Ochiai, RL, et al. Salmonella Paratyphi A rates, Asia. Emerging Infectious Diseases 2005; 11: 1764–1766.
51.Ochiai, RL, et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bulletin of the World Health Organization 2008; 86: 260–268.
52.Angell, SY, Cetron, MS. Health disparities among travelers visiting friends and relatives abroad. Annals of Internal Medicine 2005; 142: 67–72.
53.Keystone, JS. Protecting Canadian travellers: prevention is better than cure. Canadian Medical Association Journal 2008; 178: 373.
54.WHO. Typhoid vaccines: WHO position paper. Weekly Epidemiological Record 2008; 83: 49–60.